ADDPI 2021_188 INADA vs Rakesh Pandey

In April 2019 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the badminton Parathlete Sankar S. after his sample tested positive for the prohibited substances 19-norandrosterone and 19-noretiocholanolone (Nandrolone). After notification a provisional suspension was ordered and the Athlete was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).

The Athlete accepted the test result and denied the intentional use of the substances. He explained with medical evidence that for his back pain he underwent treatment in a hospital where his doctor had administered him with prescribed Deca Durabolin (Nandrolon). He mentioned this medication on the Doping Control Form and thereupon he applied for a retroactive TUE which was denied in September 2021.

INADA contended that the Athlete had acted negligently as he failed to mention to his doctor that he is an Athlete. He didn't check his medication before using and the treatment with this product is not appropriate for this condition.

The Panel finds that the presence of the prohibited subtances has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. The Panel accepts that the violation was not intentional and considers that he acted with some degree of fault or negligence.

Therefore the ADDP decides on 18 April 2022 to impose a 2 year period of ineligibility on the Parathlete, starting on the date of the provisional suspension.

Original document


Legal Source
National Decisions
18 April 2022
Arya, D.S.
Kanth, Gaurang
Kumar, Akhil
Original Source
India National Anti-Doping Agency (INADA)
Adverse Analytical Finding / presence
Legal Terms
Case law / jurisprudence
No intention to enhance performance
Period of ineligibility
Badminton (BWF) - Badminton World Federation
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Ghent, Belgium: DoCoLab Universiteit Gent-UGent
Doping classes
S1. Anabolic Agents
Nandrolone (19-nortestosterone)
Medical terms
Legitimate Medical Treatment
Parathlete / Parasports
Document type
Pdf file
Date generated
21 June 2022
Date of last modification
23 June 2022
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period